What this year’s MIPIM discussion tells us about the next phase of European expansion
For any business active in European healthcare real estate, the investment conversation is becoming more focused.
The market is still broad, but capital is becoming more selective. Investors are looking for scale, resilience and clarity. They want markets where demand is visible, operating models can perform, and long term opportunities are strong enough to justify deployment today.
At Carterwood, our current focus on the UK and Spain reflects exactly that thinking. And increasingly, Germany is coming into view as the next major market that cannot be ignored.
This year’s discussion at MIPIM 2026 reinforced why.
Spain: momentum, flexibility and a growing appetite for quality
Spain continues to attract attention, and for good reason.
From the panel discussion through to the breakout sessions, Spain stood out as one of the most attractive markets in Europe today. One of the main reasons is its private pay structure, which offers operators a degree of pricing flexibility that is highly valuable in the current environment.
That flexibility matters. It allows operators to respond to cost inflation more effectively and gives investors greater confidence in the sustainability of income. In a sector where labour costs, financing costs and development costs all remain under pressure, that is a meaningful advantage.
Spain also benefits from a market structure that many investors find attractive. It is still developing, but already large enough to support institutional interest. That combination of growth potential and increasing maturity is hard to ignore.
At the same time, the discussion made clear that Spain’s appeal is not only financial. It is also operational. The country’s demographic trajectory, combined with growing acceptance of later life accommodation and care services, creates strong fundamentals for long term investment.
For investors looking for a market where operational performance can improve over time, Spain remains one of the most compelling stories in Europe.
Germany: too important to overlook
If Spain feels like a market with momentum, Germany feels like a market with weight.
Several speakers made the point that Germany remains one of Europe’s largest healthcare real estate markets, with significant opportunities in both existing stock and future supply. That alone keeps it firmly on the radar of serious investors.
Yet Germany’s current position is more complex.
The breakout discussion on Germany pointed to strong long term demand, but also highlighted the barriers holding the market back. New development remains challenging, construction costs are high, and regulation is fragmented. The result is a market with huge need, but not always a straightforward route to delivery.
That should not be mistaken for weakness. If anything, it underlines why Germany matters.
Markets of this size do not disappear from the investment map because conditions are difficult for a period. They become even more important to understand. For investors willing to navigate complexity, Germany offers scale, demand and long term strategic relevance.
There was also notable interest in senior living and adjacent models within Germany, suggesting that future opportunity may not sit only in traditional care home formats. As the market continues to evolve, understanding which segments are viable, affordable and operationally robust will be essential.
What links the UK, Spain and Germany for property developers and investors?
At first glance, the UK, Spain and Germany look very different.
The UK offers depth and a strong private pay segment. Spain combines flexibility with momentum. Germany brings scale but also greater complexity.
Yet the discussion at MIPIM revealed a set of common themes linking all three.
Operational performance is now central
Across every market, speakers returned to the same idea. Future returns are likely to be driven less by passive yield movement and more by operational improvement. Investors can no longer afford to treat operations as someone else’s problem.
New supply is constrained everywhere
Whether the issue is planning in the UK, viability in Germany or broader delivery risk across Europe, bringing forward new healthcare stock remains difficult. That means well-located, high quality assets will remain valuable.
Market structure matters
Funding models, pricing flexibility, regulation and local cultural norms all shape investment outcomes. What works in Spain may not work in Germany. What is scalable in the UK may need adapting elsewhere.
Long term demand is not in question
No speaker challenged the demographic case. The debate is now about how to meet demand sustainably, not whether demand exists.
Expansion requires local intelligence, not just capital
One of the clearest takeaways from the session was that expansion across Europe cannot be driven by headline trends alone.
Investors need to understand local market mechanics in detail. That includes operator quality, pricing structures, regulatory environments, planning or licensing systems, labour availability and the maturity of different sub-sectors.
This is where comparative analysis becomes powerful.
Looking at Spain alongside the UK reveals how pricing freedom influences resilience. Looking at Germany alongside both shows how market scale can coexist with delivery friction. And looking across all three highlights the need to judge not just where demand is strongest, but where capital can actually be deployed well.
The next chapter of European healthcare real estate
So what does all this mean for investors?
It means the next phase of European healthcare real estate will not be won by those who simply pick the biggest market or follow the loudest narrative. It will be won by those who can combine conviction with detail.
Spain deserves the attention it is getting. The UK continues to offer a strong platform for investment. And Germany, despite current constraints, remains too important to ignore.
For businesses thinking seriously about expansion, the task now is to move beyond broad enthusiasm and into sharper market selection.
That is where the best opportunities will emerge.
